Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
First Claim
1. A method for delivering an anionic therapeutic agent to an eye which method comprises applying topically to the eye a therapeutically effective amount of a sterile, aqueous composition, said composition comprising:
- (a) an effective amount of the anionic therapeutic agent, (b) an amount of a quaternary nitrogen-containing ethoxylated glycoside in the range of from 0.001 to 10 percent by weight of the composition to hold said anionic therapeutic agent in association with the surface of the eye or a contact lens worn in the eye.
7 Assignments
0 Petitions
Accused Products
Abstract
There are disclosed compositions and methods for treating the surface of the eye, or contact tenses to be placed on the eye, with an aqueous composition comprising a quaternary nitrogen-containing ethoxylated glycoside and a therapeutic agent. The subject invention is particularly suited for use with silicone-containing contact lenses. Examples of specific compositions include aqueous solutions of lauryl methyl gluceth-10 hydroxypropyl-dimonium chloride in combination with anionic polysaccharides such as hyaluronic acid.
71 Citations
26 Claims
-
1. A method for delivering an anionic therapeutic agent to an eye which method comprises applying topically to the eye a therapeutically effective amount of a sterile, aqueous composition, said composition comprising:
-
(a) an effective amount of the anionic therapeutic agent, (b) an amount of a quaternary nitrogen-containing ethoxylated glycoside in the range of from 0.001 to 10 percent by weight of the composition to hold said anionic therapeutic agent in association with the surface of the eye or a contact lens worn in the eye. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A method for the treatment of dry eye or, with an ophthalmic drug, treating, preventing, or diagnosing disorders or diseases of the eye, which method comprises the delivery of an anionic therapeutic agent to an eye by applying an aqueous composition topically to the eye, said aqueous composition comprising:
-
(a) an effective amount of therapeutic agent, (b) an effective amount of a delivery vehicle comprising an anionic polymer; and
(c) 0.001 to 10 percent by weight of the composition of a quaternary nitrogen-containing ethoxylated glycoside to hold said therapeutic agent in association with the surface of the eye or a contact lens worn in the eye. - View Dependent Claims (8, 9, 10)
-
-
11. A method for treating dry eye comprising topically administering to an eye of a patient suffering from dry eye a composition comprising a therapeutically effective amount of a sterile, aqueous composition, said composition comprising:
-
(a) 0.001 to 10 percent by weight of the composition of a quaternary nitrogen-containing ethoxylated glycoside, (b) an effective amount of an anionic polymer effective in treating dry eye. - View Dependent Claims (12, 13, 14, 15, 16, 17)
-
- 18. A method for increasing the beneficial effect of an anionic therapeutic agent in an eye comprising prolonging the association of the therapeutic agent with the surface of the eye by administering an effective amount of a sterile, aqueous composition, said composition comprising the anionic therapeutic agent in combination with an amount of a quaternary nitrogen-containing ethoxylated glycoside in the range of from 0.001 to 10 percent by weight of the composition to hold said anionic therapeutic agent in association with the surface of the eye or a contact lens worn in the eye.
Specification